Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Zhenbo Tu, Ph.D.

Concepts (83)

Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
CCAAT-Enhancer-Binding Proteins120202860.680 Why?
Cell Cycle3202029700.580 Why?
Receptors, CCR12016380.560 Why?
Chemokines, CC120162900.510 Why?
Neoplastic Stem Cells2201913840.480 Why?
Interleukin-17120188970.430 Why?
Mesenchymal Stem Cells1202215940.420 Why?
Epithelial-Mesenchymal Transition120166970.410 Why?
Receptors, CXCR4120167240.410 Why?
Ubiquitin-Protein Ligases2202118430.410 Why?
Lung Neoplasms32022129920.360 Why?
Precursor Cell Lymphoblastic Leukemia-Lymphoma1201815070.350 Why?
Cell Transformation, Neoplastic3202229490.270 Why?
Receptor-Interacting Protein Serine-Threonine Kinases220231410.270 Why?
Cell Line, Tumor52022166720.250 Why?
Gene Knockdown Techniques2202016560.230 Why?
Heterogeneous-Nuclear Ribonucleoproteins12022720.220 Why?
Receptors, Tumor Necrosis Factor, Type I120232630.210 Why?
Phosphatidylinositol 3-Kinase120221300.200 Why?
T-Lymphocytes12018101190.190 Why?
Cell Proliferation32022104670.180 Why?
AMP-Activated Protein Kinases120236090.180 Why?
Blotting, Western2201852070.180 Why?
Gene Library1202210770.170 Why?
Tumor Microenvironment2202234800.170 Why?
DNA, Complementary1202220620.160 Why?
Cell Movement2202252430.160 Why?
Carcinoma, Non-Small-Cell Lung1201651530.160 Why?
Breast Neoplasms22022206150.160 Why?
Computational Biology2202035270.150 Why?
Signal Transduction22016234260.140 Why?
Extracellular Signal-Regulated MAP Kinases120186310.140 Why?
Stress, Physiological1202314090.130 Why?
Adipocytes1202211850.130 Why?
Xenograft Model Antitumor Assays2202135690.120 Why?
Proto-Oncogene Proteins c-akt1202225120.120 Why?
Prognosis32020289670.110 Why?
Phosphatidylinositol 3-Kinases1202229420.110 Why?
Gene Expression Profiling2202094210.100 Why?
Energy Metabolism1202329110.100 Why?
Cell Separation1201617290.100 Why?
Phenotype22019163750.090 Why?
Kaplan-Meier Estimate1202065350.090 Why?
DNA Replication1201614080.090 Why?
RNA, Messenger12022130560.070 Why?
Polymerase Chain Reaction1201661920.070 Why?
Gene Expression1202078160.070 Why?
Neoplasms12016214100.070 Why?
Flow Cytometry1201659490.070 Why?
Humans1020237369400.070 Why?
Mice32023805640.070 Why?
Drug Resistance, Neoplasm2202151520.070 Why?
Neoplasm Metastasis1201648530.060 Why?
Protein Kinase Inhibitors1202154990.060 Why?
Gene Expression Regulation, Neoplastic2202184310.060 Why?
Molecular Targeted Therapy1201627350.060 Why?
Hydroxylation120231410.060 Why?
Disease Models, Animal12022180570.060 Why?
Immunohistochemistry12016114580.060 Why?
MicroRNAs1201837210.050 Why?
Apoptosis1201897550.050 Why?
Proline120234560.050 Why?
Retinoblastoma Binding Proteins12021980.050 Why?
Sp1 Transcription Factor120211440.050 Why?
Antineoplastic Combined Chemotherapy Protocols12021113950.050 Why?
Mice, Inbred C57BL12018219700.050 Why?
Animals320231687350.050 Why?
Protein Stability120215570.040 Why?
Hypoxia-Inducible Factor 1, alpha Subunit120236290.040 Why?
Models, Biological1201696150.040 Why?
Cyclin-Dependent Kinase 6120213230.040 Why?
Female420223785100.040 Why?
Cyclin-Dependent Kinase 4120215310.040 Why?
Drug Synergism1202117960.040 Why?
Transcriptional Activation1202117880.030 Why?
Ischemia1202319330.030 Why?
Inflammation22023105050.030 Why?
Antineoplastic Agents12016136380.030 Why?
Phosphorylation1202384480.030 Why?
Male220183490250.020 Why?
Aged120161626790.020 Why?
Middle Aged120162131150.010 Why?
Adult120162132830.010 Why?
Tu's Networks
Click the
buttons for more information and interactive visualizations!
Concepts (83)
Co-Authors (17)
Similar People (60)
Same Department 
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.